Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al

Affiliations

¹ Rheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia, and Department of Clinical and Experimental Sciences, University of Brescia, Italy. slv.piantoni@gmail.com.
² Rheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia, Italy.
³ Department of Molecular and Translational Medicine, University of Brescia, Italy.
⁴ Rheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia, and Department of Clinical and Experimental Sciences, University of Brescia, Italy.

Free article

Comment

Silvia Piantoni et al. Clin Exp Rheumatol. 2021 Sep-Oct.

Free article

. 2021 Sep-Oct;39(5):1144.

doi: 10.55563/clinexprheumatol/bxyfgc. Epub 2021 Mar 5.

¹ Rheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia, and Department of Clinical and Experimental Sciences, University of Brescia, Italy. slv.piantoni@gmail.com.
² Rheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia, Italy.
³ Department of Molecular and Translational Medicine, University of Brescia, Italy.
⁴ Rheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia, and Department of Clinical and Experimental Sciences, University of Brescia, Italy.

No abstract available

Comment on

Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis. Comment on: Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept.
Castellanos-Moreira R, Gomez A, Haro I, Ruiz-Esquide V, Marsal S, Sanmarti R. Castellanos-Moreira R, et al. Clin Exp Rheumatol. 2021 Sep-Oct;39(5):1142-1143. doi: 10.55563/clinexprheumatol/gh5eq7. Epub 2021 Mar 3. Clin Exp Rheumatol. 2021. PMID: 33666163 No abstract available.